During the process, influx of glucose ensures sufficient ATP to sustain the stimulatory effect
Serious side effects were uncommon (0% to 6% in trials), but as with other GLP-1based drugs, rare risks such as pancreatitis, gallbladder problems, or thyroid tumors (in animal studies) remain a concern
GLP-1 receptor agonists, such as Semaglutide and Tirzepatide, mimic these effects, making them effective for diabetes management
According to the Reuters report, Eli Lilly denied the allegations on Tuesday and said it stands by its advertising, adding that it intends to vigorously defend itself
But it may be one of the things you do to improve your health